VEENA RAO
Profile
First Name
: VEENA
Middle Name
:
Last Name
: RAO
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
MARTHA ARONSON, AMANDA BLACK, BETH BROOKE, MARCIE CAIN, SEAN CARNEY, SEAN D. CARNEY, PARKER CASSIDY, GIBB CLARKE, GILBERT CLARKE, EDWARD DAMIANO, EDWARD R. DAMIANO, FRANCESCO DRAETTA, WESTLEY DUPRAY, STEPHEN H. FEIDER, THOMAS A. FITZGERALD, CHRISTIAN FOGED, GILAD GLICK, JEFF HITCHCOCK, JEFFREY HITCHCOCK, DEIRDRE IBSEN, CHRISTY JONES, LENNOX KETNER, FINNY KURUVILLA, MARTIN H LANGE, AGUSTIN MOHEDAS, MICHAEL PEREIRA, EDWARD RASKIN, EDWARD B. RASKIN, SERAFINA RASKIN, MIKE ROSINKO, MIKE ROSKINO, SEAN T. SAINT, ADAM STEENSBERG
DIRECTOR
RAYMOND F. BENNARE, JOSH BLACHER, NANCY CHUNG-WELCH, JAMES E. DAUWALTER, KEVIN R. DAVIDSON, KIRSTEN DOERFERT, ARNON DREYFUSS, J MELVILLE ENGLE, RICHARD L GABRIEL, LAWRENCE W. GADBAW, JEFFREY GALITZ, DAN HADLEY, DANIEL E HANDLEY, MATTHEW HAWRYLUK, CHRISTINA JENKINS, DAVID JOHNSON, RICARDO KOENIGSBERGER, JOSHUA KORNBERG, TIMOTHY A KROCHUK, FRANK MANCUSO, SHAWN MATTHEWS, THOMAS MCGOLDRICK, THOMAS J. MCGOLDRICK, THOMAS L. MCLAUGHLIN, PETER L. MORAWETZ, BOB MYERS, ROBERT MYERS, CHUCK NUZUM, PAM S PRIOR, ANDREW REDING, ANDREW P REDING, ANDREW P. REDING, CHAD A. RUWE, CARL SCHWARTZ, CARL I SCHWARTZ, ALAN SHULER, GREGORY ST. CLAIR, GREGORY S ST. CLAIR SR., GREGORY S. ST. CLAIR, SR., GERALD J VARDZEL, RAYMOND VENNARE, RAYMOND F. VENNARE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842]
DECLINE TO DISCLOSE
2025-10-07
D
OTHER
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842]
DECLINE TO DISCLOSE
Equity
2025-10-07
D
BIOTECHNOLOGY
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842]
DECLINE TO DISCLOSE
Equity
2025-08-26
D
BIOTECHNOLOGY
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842]
$1,000,001 - $5,000,000
2024-07-26
D
OTHER HEALTH CARE
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2022-02-16
